Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.4000 (-7.27%) ($7.2900 - $7.4000) on Fri. Jun. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.86% (three month average) | RSI | 42 | Latest Price | $7.4000(-7.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SDY(26%) BND(25%) XLRE(25%) VYM(23%) ARKG(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.43% in a week (0% probabilities). VIXM(-25%) VXX(-22%) TLT(-18%) VCIT(-17%) SHY(-17%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.43% (StdDev 2.86%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $0.09(-98.78%) | Resistance Level | $8.29 | 5 Day Moving Average | $7.97(-7.15%) | 10 Day Moving Average | $8.27(-10.52%) | 20 Day Moving Average | $8.29(-10.74%) | To recent high | -16.4% | To recent low | 0.3% | Market Cap | $1.306b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |